Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Preferred Shares (2021 - 2025)

Historic Preferred Shares for Bioadaptives (BDPT) over the last 5 years, with Q3 2025 value amounting to $100.0.

  • Bioadaptives' Preferred Shares fell 7500.0% to $100.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $100.0 for FY2024, which is 990000.0% up from last year.
  • According to the latest figures from Q3 2025, Bioadaptives' Preferred Shares is $100.0, which was down 7500.0% from $100.0 recorded in Q2 2025.
  • Over the past 5 years, Bioadaptives' Preferred Shares peaked at $400.0 during Q3 2024, and registered a low of $1.0 during Q4 2023.
  • For the 5-year period, Bioadaptives' Preferred Shares averaged around $174.78, with its median value being $160.0 (2021).
  • Its Preferred Shares has fluctuated over the past 5 years, first crashed by 9937.5% in 2023, then surged by 990000.0% in 2024.
  • Bioadaptives' Preferred Shares (Quarter) stood at $160.0 in 2021, then changed by 0.0% to $160.0 in 2022, then tumbled by 99.38% to $1.0 in 2023, then soared by 9900.0% to $100.0 in 2024, then changed by 0.0% to $100.0 in 2025.
  • Its Preferred Shares stands at $100.0 for Q3 2025, versus $100.0 for Q2 2025 and $100.0 for Q1 2025.